Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
New collaboration aims to enhance colorectal cancer screening accuracy
, /in E-News, Tumour Markers /by panglobalA new partnership between Surfix Diagnostics, the Netherlands Cancer Institute (NKI), and CRCbioscreen will focus on the validation of novel biomarkers for colorectal cancer (CRC) screening. The collaboration, supported by a PPP grant from the TKI-program Life Sciences & Health of Health~Holland, aims to address the limitations of current screening methods and potentially revolutionise early […]
SciRhom raises €63 million to advance iRhom2-targeting therapies for autoimmune diseases
, /in Autoimmunity & Allergy, E-News /by panglobalMunich-based biopharmaceutical company SciRhom GmbH has secured a substantial €63 million (US$70 million) in Series A financing to accelerate the development of its pioneering iRhom2-targeting antibodies for autoimmune disorders. The oversubscribed funding round, co-led by Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners, will propel the company’s lead candidate toward clinical proof-of-concept […]
Newcells Biotech bolsters commercial team with key appointment
, /in E-News /by panglobalNewcastle-based drug discovery partner Newcells Biotech has appointed Emile Shaffu as Director of Sales. This strategic move aims to strengthen the company’s global market presence and enhance customer support in the field of in vitro models and bespoke assay services.
Cellular Origins acquires ACTIA Platform to enhance automated cell therapy production
, /in E-News, Molecular Diagnostics /by panglobalCellular Origins, a TTP company specialising in cell and gene therapy (CGT) manufacturing solutions, has announced the acquisition of the Autologous Cell Therapy Industrial Automation (ACTIA) Platform intellectual property. The acquisition is set to augment the company’s existing Constellation™ platform, which was launched in May 2023.
Together at the pulse of neurobiology
, /in Featured Articles, Autoimmunity & Allergy, Molecular Diagnostics, Rapid Tests & POC /by panglobalA unique portfolio of neurobiomarker tests The testing landscape for neurological diseases has expanded rapidly in recent years due to the characterisation of many novel biomarkers. With over 15 years of experience in neurological analytics, EUROIMMUN offers an unparalleled portfolio of assays for determination of more than 80 neurobiomarkers in autoimmune diseases, neurological infections and […]
Beckman Coulter Diagnostics is committed to innovation and growth in Ireland
, /in Featured Articles /by panglobalIn July 2024, Beckman Coulter Diagnostics announced a €10 million investment and 80 jobs for its site in mid-west Ireland. CLI caught up with Kevin O’Reilly, President of Beckman Coulter Diagnostics, to find out more about the company’s aims, its commitment to the site in Ireland, and how a world-class diagnostics development facility can be […]
INTEGRA Your reliable partner for productive pipettes
, /in Featured Articles /by panglobalINTEGRA is a leading provider of high quality laboratory tools and consumables for liquid handling. We are committed to fulfilling the needs of laboratory professionals in research, diagnostics and quality control within the life sciences industry.
Biosynth’s custom peptide quotation tool now fully automatic
, /in Product News /by panglobalBiosynth, a supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceuticals, has unveiled the next step in its custom peptide revolution.
Bio-Rad’s SpyLock technology accelerates bispecific antibody development
, /in Product News /by panglobalBio-Rad Laboratories has announced the publication of a study in Nature Communications demonstrating the utility of its SpyLock technology for rapid generation and screening of bispecific antibodies. The research, titled “Engineered Reversible Inhibition of SpyCatcher Reactivity Enables Rapid Generation of Bispecific Antibodies”, highlights a novel method to modify the functional activity of SpyCatcher protein, potentially […]
Indica Labs unveils AI-powered macrodissection tool for lung cancer
, /in Product News, Tumour Markers /by panglobalIn a significant advancement for molecular pathology, Indica Labs has launched Lung Macrodissect AI, a novel tool designed to streamline slide macrodissection workflows. The announcement marks a pivotal step in integrating artificial intelligence with digital pathology.